Product Images Valsartan And Hydrochlorothiazide
View Photos of Packaging, Labels & Appearance
- Figure 1: Probability of Achieving Systolic Blood Pressure <140 mmHg at Week 8 - valhyctz fig1
- 63187-694-90 - valhyctz fig12
- Figure 2: Probability of Achieving Diastolic Blood Pressure <90 mmHg at Week 8 - valhyctz fig2
- Figure 3: Probability of Achieving Systolic Blood Pressure <130 mmHg at Week 8 - valhyctz fig3
- Figure 4: Probability of Achieving Diastolic Blood Pressure <80 mmHg at Week 8 - valhyctz fig4
- Valsartan Chemical Structure - valhyctz str1
- Hydrochlorothiazide Chemical Structure - valhyctz str2
Product Label Images
The following 7 images provide visual information about the product associated with Valsartan And Hydrochlorothiazide NDC 63187-694 by Proficient Rx Lp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1: Probability of Achieving Systolic Blood Pressure <140 mmHg at Week 8 - valhyctz fig1
This text describes a visual aid, Figure 1, which shows the probability of achieving systolic blood pressure under 140 mmHg after 8 weeks of treatment with Valsartan and Hydrochlorothiazide, compared to placebo. The doses of the active ingredients are presented (320 mg and 25 mg respectively), as well as a baseline measurement of blood pressure. The number "2883223288" appears unrelated to the topic.*
63187-694-90 - valhyctz fig12
This is a medication called Valsartan HCTZ 320mg / 25mg with product ID RV069490, manufactured by Aurobindo Pharma Limited in India. It contains 90 yellow, oval-shaped, film-coated tablets with 'I' on one side and '65' on the other side, and is stored at 20°-25°C (68°-77°F). It has a Master SN# and a lot number of 00000 with an expiration date of 00/00/00. It is RX only and should be kept out of reach of children. It has been relabeled by Proficient Rx LP in Thousand Oaks, CA 91320.*
Figure 2: Probability of Achieving Diastolic Blood Pressure <90 mmHg at Week 8 - valhyctz fig2
This is a graph showing the probability of achieving diastolic blood pressure below 90 mmHg at week 8, based on different baseline DBP levels. The graph shows three different data points at 95, 100, and 105 for baseline DBP.*
Figure 3: Probability of Achieving Systolic Blood Pressure <130 mmHg at Week 8 - valhyctz fig3
The graph displays the probability of achieving a systolic blood pressure below 130 mmHg at week 8. The study involved the use of Valsartan and Hydrochlorothiazide at doses of 320mg/25mg and 284mg, respectively, compared to a placebo. The baseline systolic blood pressure ranged from 140-180 mmHg.*
Figure 4: Probability of Achieving Diastolic Blood Pressure <80 mmHg at Week 8 - valhyctz fig4
This text describes a clinical trial evaluating the effectiveness of Valsartan and Hydrochlorothiazide in reducing diastolic blood pressure (DBP) below 80 mmHg. The trial tested a combination of Valsartan 320 mg and Hydrochlorothiazide 25 mg against a placebo, and the results are presented graphically in Figure 4, showing the probability of achieving the target DBP at Week 8.*
Valsartan Chemical Structure - valhyctz str1
Hydrochlorothiazide Chemical Structure - valhyctz str2
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
